Back to search
FDAFDA · Food and drugs·Recall number D-1145-2017

Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY

Published September 20, 2017 · Recall initiated: July 21, 2017

Summary

FDA records drug Class I recall D-1145-2017, published September 20, 2017 and initiated July 21, 2017. Recalling firm: Chiavna Saffron LLC; Status: Terminated; Reported quantity: 211 bottles; 339 boxes; Lot: a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Chiavna Saffron LLC
Distributor
Nationwide
UPC
6015577513247
Lot
a) RO846356 Exp. 8/28/2020; b) RO246852 Exp. 8/28/2020
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Super Panther 7K Capsules 1250 mg blend, a) 1 count blister cards shipped in boxes of 30 (UPC# 6015577513247); and b) 6 count bottles (UPC# 601577513209), Distributed by SX Power CO., Brooklyn, NY recalled?

Yes. FDA published recall D-1145-2017 on September 20, 2017. Reported hazard: Marketed without an Approved NDA/ANDA;FDA analysis found product to be tainted with sildendafil and tadalafil

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 6015577513247.